1.- Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020;579:270-273. doi: 10.1038/s41586-020-2012-7. 2.- Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomedica Mattioli 1885. 2020;91:157-160. 3.- Creech C, Walker S, Samuels R. SARS-CoV-2 Vaccines. JAMA. April 6, 2021 Volume 325, Number 13. 1318-1320. 4.- Dong, Y., Dai, T., Wei, Y. et al. A systematic review of SARS-CoV-2 vaccine candidates. Sig Transduct Target Ther 5, 237 (2020). https://doi.org/10.1038/ s41392-020-00352. 5.- Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines. 2021 Jan;20(1):23-44. doi: 10.1080/14760584.2021.1875824. 6.- Krammer, F. SARS-CoV-2 vaccines in development. Nature 586, 516–527 (2020). https://doi.org/10.1038/s41586-020-2798-3. 7.- Frenck RW Jr, Klein NP, Kitchin N, Gurtman A, Absalon J, Lockhart S, Perez JL, Walter EB, Senders S, Bailey R, Swanson KA, Ma H, Xu X, Koury K, Kalina WV, Cooper D, Jennings T, Brandon DM, Thomas SJ, Türeci Ö, Tresnan DB, Mather S, Dormitzer PR, Şahin U, Jansen KU, Gruber WC; C4591001 Clinical Trial Group. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med. 2021 Jul 15;385(3):239-250. doi: 10.1056/ NEJMoa2107456. 8.- Diaz GA, Parsons GT, Gering SK, Meier AR, Hutchinson IV, Robicsek A. Myocarditis and Pericarditis After Vaccination for COVID-19. JAMA. 2021 Sep 28;326(12):1210-1212. doi: 10.1001/jama.2021.13443. PMID: 34347001; PMCID: PMC8340007. 9.- Dionne A, Sperotto F, Chamberlain S, Baker AL, Powell AJ, Prakash A, Castellanos DA, Saleeb SF, de Ferranti SD, Newburger JW, Friedman KG. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children. JAMA Cardiol. 2021 Aug 10:e213471. doi: 10.1001/jamacardio.2021.3471. 10.- Das BB, Kohli U, Ramachandran P, Nguyen HH, Greil G, Hussain T, Tandon A, Kane C, Avula S, Duru C, Hede S, Sharma K, Chowdhury D, Patel S, Mercer C, Chaudhuri NR, Patel B, Ang JY, Asmar B, Sanchez J, Khan D. Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. J Pediatr. 2021 Nov;238:26-32.e1. doi: 10.1016/j.jpeds.2021.07.044. 11.- Han B, Song Y, Li C, Yang W, Ma Q, Jiang Z, Li M, Lian X, Jiao W, Wang L, Shu Q, Wu Z, Zhao Y, Li Q, Gao Q. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021 Jun 28:S1473-3099(21)00319-4. doi: 10.1016/S1473-3099(21)00319-4. 12.- https://www.ispch.cl/wp-content/uploads/2021/10/20211021-Informe-estadistico-ESAVI-ninos-6-y-11-anos-VFinal.pdf. 13.- Li Z, Guan X, Mao N, Luo H, Qin Y, He N, Zhu Z, Yu J, Li Y, Liu J, An Z, Gao W, Wang X, Sun X, Song T, Yang X, Wu M, Wu X, Yao W, Peng Z, Sun J, Wang L, Guo Q, Xiang N, Liu J, Zhang B, Su X, Rodewald L, Li L, Xu W, Shen H, Feng Z, Gao GF. Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China. Lancet Reg Health West Pac. 2021 Mar;8:100094. doi: 10.1016/j. lanwpc.2021.100094. 14.- Loenenbach A, Markus I, Lehfeld AS, An der Heiden M, Haas W, Kiegele M, Ponzi A, Unger-Goldinger B, Weidenauer C, Schlosser H, Beile A, Buchholz U. SARS-CoV-2 variant B.1.1.7 susceptibility and infectiousness of children and adults deduced from investigations of childcare centre outbreaks, Germany, 2021. Euro Surveill. 2021 May;26(21):2100433. doi: 10.2807/1560-7917.ES.2021.26.21.2100433. 15.- American Academy of Pediatrics. Children and COVID-19: statelevel data report, 2021. https://www.aap.org/en/pages/2019-novelcoronavirus-covid-19- infections/children-and-covid-19-state-leveldata-report/. Accessed 30 Aug 2021. 16.- http://epi.minsal.cl/wp-content/uploads/2021/09/Informe-epidem-COVID-19_NNA_SE36_Final.pdf. 17.- Xue FX, Shen KL. COVID-19 in children and the importance of COVID-19 vaccination. World J Pediatr. 2021 Oct;17(5):462-466. doi: 10.1007/s12519-021- 00466-5. Epub 2021 Sep 28. PMID: 34581958; PMCID: PMC8476974. 18.- https://www.minsal.cl/wp-content/uploads/2021/08/Sindrome-Inflamatorio-Multisistemico-en-Ninos-Ninas-y-Adolescentes.pdf. 19.- Xu CLH, Raval M, Schnall JA, Kwong JC, Holmes NE. Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data. Pediatr Infect Dis J. 2020 Sep;39(9):e249-e256. doi: 10.1097/INF.0000000000002814. 20.- Abbas K, Mogasale V. Disruptions to childhood immunisation due to the COVID-19 pandemic. Lancet. 2021;398:469–71. 21.- https://www.unicef.org/es/coronavirus/reabrir-escuelas?gclid=CjwKCAiA1aiMBhAUEiwACw25MVGMDAFZ_0XmuU3hRl8wA4gihXaajNWA1VjcQ4L4YIeXqQsY2chrq xoCbaEQAvD_BwE. 22.- Racine N, McArthur BA, Cooke JE, Eirich R, Zhu J, Madigan S. Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis. JAMA Pediatr. 2021. https://doi.org/10.1001/jamapediatrics.2021.2482. Referencias: 18 diciembre 2021. Volumen 20 - N°81
RkJQdWJsaXNoZXIy MTYwMjk1